Clinician's Guide for Pediatric Anti-obesity Medications.

Creator(s)

Wesley P. Dutton
Nina Paddu
Amy Braddock
Brooke Sweeney, Children's Mercy Kansas CityFollow

Document Type

Article

Publication Date

10-2024

Identifier

DOI: 10.1016/j.pcl.2024.07.006

Abstract

The recent advent of highly effective anti-obesity medications (AOM) provides pediatric clinicians a powerful tool to augment the treatment of obesity and improve outcomes. The 2023 American Academy of Pediatrics guidelines state clinicians "should offer adolescents 12 years and older with obesity weight loss pharmacotherapy, according to medication indications, risks, and benefits, as an adjunct to health behavior and lifestyle treatment". This article will provide an update on the integration of AOM into practice, emphasizing clinical pearls and practical tips.

Journal Title

Pediatric clinics of North America

Volume

71

Issue

5

First Page

957

Last Page

980

MeSH Keywords

Humans; Anti-Obesity Agents; Pediatric Obesity; Child; Adolescent; Practice Guidelines as Topic; Weight Loss

Keywords

Anti-obesity medications; Pediatric obesity; Pharmacotherapy; Treatment

Recommended Citation

Dutton WP, Paddu N, Braddock A, Sweeney B. Clinician's Guide for Pediatric Anti-obesity Medications. Pediatr Clin North Am. 2024;71(5):957-980. doi:10.1016/j.pcl.2024.07.006